163 related articles for article (PubMed ID: 10650934)
1. Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells.
Monno S; Newman MV; Cook M; Lowe WL
Endocrinology; 2000 Feb; 141(2):544-50. PubMed ID: 10650934
[TBL] [Abstract][Full Text] [Related]
2. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
3. Anchorage-independent activation of mitogen-activated protein kinase through phosphatidylinositol-3 kinase by insulin-like growth factor I.
Suzuki K; Takahashi K
Biochem Biophys Res Commun; 2000 May; 272(1):111-5. PubMed ID: 10872812
[TBL] [Abstract][Full Text] [Related]
4. Activation of phosphatidylinositol 3-kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic beta-cell death.
Liu W; Chin-Chance C; Lee EJ; Lowe WL
Endocrinology; 2002 Oct; 143(10):3802-12. PubMed ID: 12239091
[TBL] [Abstract][Full Text] [Related]
5. IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase.
Kooijman R; Coppens A; Hooghe-Peters E
Cell Signal; 2003 Dec; 15(12):1091-8. PubMed ID: 14575864
[TBL] [Abstract][Full Text] [Related]
6. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
Lin CW; Yang LY; Shen SC; Chen YC
J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase.
Okubo Y; Blakesley VA; Stannard B; Gutkind S; Le Roith D
J Biol Chem; 1998 Oct; 273(40):25961-6. PubMed ID: 9748273
[TBL] [Abstract][Full Text] [Related]
8. LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes.
Shoba LN; Newman M; Liu W; Lowe WL
Endocrinology; 2001 Sep; 142(9):3980-6. PubMed ID: 11517177
[TBL] [Abstract][Full Text] [Related]
9. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
Krause D; Lyons A; Fennelly C; O'Connor R
J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I.
Cheng HL; Feldman EL
J Biol Chem; 1998 Jun; 273(23):14560-5. PubMed ID: 9603971
[TBL] [Abstract][Full Text] [Related]
11. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes.
Walsh PT; Smith LM; O'Connor R
Immunology; 2002 Dec; 107(4):461-71. PubMed ID: 12460191
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
14. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
17. The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-I-mediated effects in vascular endothelial cells.
Liu W; Liu Y; Lowe WL
Endocrinology; 2001 May; 142(5):1710-9. PubMed ID: 11316733
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I.
Ryu BR; Ko HW; Jou I; Noh JS; Gwag BJ
J Neurobiol; 1999 Jun; 39(4):536-46. PubMed ID: 10380075
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line.
Kodama Y; Baxter RC; Martin JL
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):336-44. PubMed ID: 12204896
[TBL] [Abstract][Full Text] [Related]
20. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
